nedaplatin has been researched along with Stomach Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dan, N; Hirakawa, K; Kubo, N; Morimoto, J; Muguruma, K; Nishiguchi, Y; Oohira, M; Sawada, T; Tanaka, H; Yamashita, Y; Yashiro, M | 1 |
| Arai, H; Hirakata, A; Kawamoto, M; Maruyama, H; Matsushita, A; Matsutani, T; Sasajima, K; Suzuki, S; Uchida, E; Umakoshi, M; Wakabayashi, H; Yokoyama, T | 1 |
| Abe, K; Ishikawa, Y; Jingu, K; Kubozono, M; Matsushita, H; Nemoto, K; Shirata, Y; Sugawara, T; Takahashi, C; Takeda, K; Tanabe, T; Umezawa, R; Yamamoto, T | 1 |
| Matsumoto, T; Mikami, T; Momokawa, K; Nakamura, Y; Sakayauchi, T; Sasaki, T; Watanabe, T | 1 |
| Ariyama, H; Baba, E; Harada, M; Kusaba, H; Mitsugi, K; Nakano, S; Qin, B; Shibata, Y; Takii, Y; Tanaka, R | 1 |
| Chung, YS; Kato, Y; Kubo, T; Maeda, K; Nakata, B; Nitta, A; Okuno, M; Sowa, M; Yashiro, M | 1 |
| Isono, K; Kakegawa, T; Kurihara, M; Nabeya, K; Ota, K; Taguchi, T; Wakui, A | 1 |
| Hirabayashi, K; Oguma, T; Okada, E; Shimamura, K | 1 |
2 trial(s) available for nedaplatin and Stomach Neoplasms
| Article | Year |
|---|---|
Long-term results of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: update on a phase II study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Drug Administration Schedule; Esophageal Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Postoperative Period; Prognosis; Stomach Neoplasms; Time Factors; Treatment Outcome | 2012 |
[A phase II clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group].
Topics: Antineoplastic Agents; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation; Esophageal Neoplasms; Humans; Infusions, Intravenous; Leukopenia; Middle Aged; Nausea; Organoplatinum Compounds; Stomach Neoplasms; Thrombocytopenia | 1992 |
6 other study(ies) available for nedaplatin and Stomach Neoplasms
| Article | Year |
|---|---|
[A case of stage IV advanced esophageal cancer with a long term survival by radiation therapy combined with nedaplatin and 5-FU chemotherapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Fluorouracil; Gastrectomy; Humans; Male; Neoplasm Staging; Neoplasms, Multiple Primary; Organoplatinum Compounds; Stomach Neoplasms | 2009 |
[A successful resected case of far-advanced cancer at the esophagogastric junction by chemoradiotherapy with docetaxel, nedaplatin and 5-fluorouracil].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Fatal Outcome; Fluorouracil; Humans; Male; Neoplasm Staging; Organoplatinum Compounds; Stomach Neoplasms; Taxoids | 2010 |
[Effect of steroid on antiemetic for side effect of anticancer chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Esophageal Neoplasms; Fluorouracil; Humans; Male; Metoclopramide; Middle Aged; Nausea; Organoplatinum Compounds; Serotonin Antagonists; Stomach Neoplasms; Vomiting, Anticipatory | 2005 |
In vitro sequence-dependent interaction between nedaplatin and paclitaxel in human cancer cell lines.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Drug Combinations; Drug Interactions; Humans; Organoplatinum Compounds; Paclitaxel; Stomach Neoplasms | 2005 |
[Experimental study on the anti-tumor effect of CDDP derivatives against the gastric cancer cell lines].
Topics: Adenocarcinoma; Antineoplastic Agents; Carboplatin; Cell Division; Cisplatin; Humans; Organoplatinum Compounds; Stomach Neoplasms; Tumor Cells, Cultured | 1994 |
[Pharmacokinetics of cis-diammine (glycolato) platinum (254-S), a new platinum antitumor agent, following an intravenous and intraperitoneal infusion bioactive platinum concentration profile].
Topics: Aged; Antineoplastic Agents; Biological Assay; Female; Humans; Infusions, Intravenous; Infusions, Parenteral; Middle Aged; Organoplatinum Compounds; Peritonitis; Platinum; Stomach Neoplasms; Uterine Cervical Neoplasms | 1990 |